TY - JOUR AU - Cafuir, Lorraine AU - Lawson, David AU - Desai, Nilesh AU - Kesner, Vita AU - Voloschin, Alfredo PY - 2018 DA - 2018/01/30 TI - Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab JO - Journal for ImmunoTherapy of Cancer SP - 11 VL - 6 IS - 1 AB - Ipilimumab is an FDA-approved anti-CTLA-4 monoclonal antibody used in treatment of metastatic melanoma. We present an unusual neurological complication of Ipilimumab therapy and the diagnostic dilemma it caused. SN - 2051-1426 UR - https://doi.org/10.1186/s40425-018-0318-x DO - 10.1186/s40425-018-0318-x ID - Cafuir2018 ER -